Is an effective immune intervention for Alzheimer's disease in prospect?

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.22, Iss.1, 2001-01, pp. : 2-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetics of late-onset Alzheimer’’s disease: progress and prospect

By Li Yonghong Grupe Andrew

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1747-1755

Future Medicine

Access to resources Recommend Favorite

Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer's Disease: Potential for Pharmacological Intervention

By Kivipelto M.

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 435-444

Adis International

Access to resources Recommend Favorite

Cholinergic Nicotinic Systems in Alzheimer's Disease: Prospects for Pharmacological Intervention

By Vesey R.

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 485-500

Adis International

Access to resources Recommend Favorite

Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer's Disease: Prospects, Limitations and Strategies

By Evin Geneviève Marijke Fleur Sernee Masters Colin L.

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 351-372

Adis International

Access to resources Recommend Favorite

Therapeutic intervention for Alzheimer's disease with γγ-secretase inhibitors: still a viable option?

By Imbimbo Bruno P Panza Francesco Frisardi Vincenza Solfrizzi Vincenzo D'Onofrio Grazia Logroscino Giancarlo Seripa Davide Pilotto Alberto

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 325-341

Informa Healthcare

Access to resources Recommend Favorite